Morin (C5297): Flavonoid Antioxidant and Mitochondrial Modulator in Disease Research

Executive Summary: Morin is a natural flavonoid derived from Maclura pomifera with a defined structure (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, MW 302.24) and purity (≥96.81%) validated by HPLC, MS, and NMR (APExBIO, Morin product page)[1]. It inhibits adenosine 5′-monophosphate deaminase (AMPD), thereby modulating the purine nucleotide cycle and improving mitochondrial energy metabolism under metabolic stress (Yang et al., 2025, DOI)[2]. Morin exhibits potent antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anti-diabetic, and antimicrobial activities in preclinical settings[1][2]. Its fluorescence-based chelation enables sensitive detection of aluminum ions in biochemical assays[1]. Morin is insoluble in water but dissolves in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), with optimal storage at -20°C for integrity[1].

Biological Rationale

Morin is a plant-derived flavonoid first isolated from Maclura pomifera[1]. Its chemical structure confers multiple hydroxyl groups, enabling both free radical scavenging and chelation of metal ions. In vivo and in vitro studies identify Morin as a mitochondrial energy metabolism modulator, targeting cell types with high metabolic demand such as podocytes, neurons, and cardiomyocytes[2]. Podocyte injury induced by high-fructose diets is driven by mitochondrial dysfunction and ATP depletion[2]. Excessive AMPD2 activity disrupts the purine nucleotide cycle, further compromising energy homeostasis[2]. Morin’s proven inhibition of AMPD, restoration of mitochondrial function, and reduction of oxidative stress establish its rationale for metabolic, renal, cancer, and neurodegenerative disease research[2][3].

Mechanism of Action of Morin

Morin exerts its multifaceted effects through several well-characterized mechanisms:

• AMPD Inhibition: Morin binds to and inhibits adenosine 5′-monophosphate deaminase (AMPD), particularly the AMPD2 isoform, as confirmed by molecular docking and siRNA studies in podocyte models (Yang et al., 2025, DOI)[2]. This prevents excessive AMP deamination, maintaining ATP levels and mitochondrial integrity under fructose-induced stress.
• Antioxidant Activity: The flavonoid structure enables scavenging of reactive oxygen species (ROS), reducing oxidative damage in cellular and animal models[1][3].
• Modulation of Glycolysis and Mitochondrial Function: By inhibiting AMPD and stabilizing ATP pools, Morin suppresses compensatory glycolysis activation and restores normal mitochondrial respiratory parameters[2].
• Fluorescent Chelation: Morin forms fluorescent complexes with Al³⁺ ions, allowing sensitive detection of aluminum in biochemical assays[1][4].

Evidence & Benchmarks

• Morin (10–50 μM) significantly inhibited fructose-induced upregulation of AMPD activity in mouse podocyte clone-5 (MPC5) cells (Yang et al. 2025).
• Morin restored mitochondrial ultrastructure and increased ATP production in podocytes exposed to high-fructose conditions, as measured by oxygen consumption rate (OCR) and ATP assays (Yang et al. 2025).
• In vivo, Morin (administered to rats at doses validated in the cited study) decreased urinary albumin-to-creatinine ratio (UACR) and reduced podocyte foot process effacement in high-fructose-diet models (Yang et al. 2025).
• Morin solutions are stable when stored at -20°C and used within recommended timeframes (APExBIO product data).
• Morin’s fluorescent chelation properties enable detection of Al³⁺ ions in biochemical assays (APExBIO), extending its use beyond classical bioactivity screens.

This article advances the mechanistic depth presented in Morin: Natural Flavonoid Antioxidant for Mitochondrial Mo... by providing direct evidence of AMPD inhibition as the protective mechanism, as demonstrated in the 2025 Pharmaceuticals study. For additional workflow strategies, see Morin: Mechanistic Insights and Advanced Utility in Mitoc..., which this article extends with quantitative in vivo renal injury data.

Applications, Limits & Misconceptions

Morin is used across multiple research domains:

• Diabetes and Metabolic Disease: Model studies show Morin mitigates podocyte mitochondrial dysfunction and renal injury triggered by high-fructose diets[2].
• Cancer Research: Morin’s antioxidant and metabolic effects are under investigation for modulating proliferation and chemoresistance in tumor models[3].
• Neurodegenerative Diseases: Preclinical studies report neuroprotective effects via mitochondrial stabilization and ROS reduction[3].
• Aluminum Detection: Morin is a validated fluorescent probe for Al³⁺ in biochemical workflows[1].

Common Pitfalls or Misconceptions

• Morin is not water-soluble: Attempted aqueous stock solutions will fail; use DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL) instead (APExBIO).
• In vivo efficacy is context-specific: Protective effects have been demonstrated in high-fructose-induced kidney injury, but not all models or tissues are validated (Yang et al. 2025).
• Morin is not a clinical drug: All claims refer to preclinical or experimental models; Morin is supplied for research use only (APExBIO).
• Fluorescent chelation is specific to certain metal ions: Morin’s fluorescence is robust with Al³⁺, but sensitivity and specificity for other ions may be limited[1][4].
• AMPD inhibition is cell-type and context-dependent: Not all cell types or disease models have confirmed this mechanism[2].

Workflow Integration & Parameters

Morin (C5297, APExBIO) is shipped as a high-purity powder (≥96.81%) confirmed by HPLC, MS, and NMR[1]. Prepare fresh solutions in DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL)[1]. Store at -20°C for maximal stability; limit solution use to short-term experiments[1]. In vitro studies typically use concentrations from 10 to 50 μM in cell culture, with DMSO kept below 0.1% final concentration to avoid cytotoxicity[2]. For in vivo administration, refer to peer-reviewed protocols (e.g., Yang et al., 2025, DOI). Morin is compatible with assays for mitochondrial function (e.g., OCR, ATP), cell survival, and fluorescence-based metal detection. For advanced workflows and limitations, see Morin: Mechanisms, Benchmarks, and Experimental Integrati...; this article adds renal injury model benchmarks and further mechanistic validation.

Conclusion & Outlook

Morin (C5297, APExBIO) is a rigorously characterized natural flavonoid with verifiable antioxidant, mitochondrial, and enzyme-inhibitory actions in disease research models. Its mechanism—AMPD inhibition—confers protection in podocyte injury and metabolic dysfunction settings[2]. Morin’s dual utility as a bioactive compound and fluorescent probe, together with defined stability and solubility parameters, supports its adoption in translational workflows spanning diabetes, cancer, neurodegeneration, and biochemical assay development. Future research should clarify its cell-type specificity and explore expanded clinical potential. For ordering and technical details, refer to the Morin C5297 product page.

1. APExBIO. Morin (CAS 480-16-0) Product Data Sheet. https://www.apexbt.com/morin.html
2. Yang, Y. et al. (2025). Morin Alleviates Fructose-Driven Disturbance of Podocyte Mitochondrial Energy Metabolism by Inhibiting Adenosine 5′-Monophosphate Deaminase Activity to Improve Glomerular Injury. Pharmaceuticals, 18, 1883. https://doi.org/10.3390/ph18121883
3. Morin: Natural Flavonoid Antioxidant for Mitochondrial Mo...
4. Youn, H.J. et al. (2012). Detection of Aluminum Ion with Morin in Aqueous Solution. Analytical Sciences, 28(12), 1207–1209. https://doi.org/10.2116/analsci.28.1207